Background illustration for clinical trials search

Paid Clinical Trials Colorado

Discover 1,688 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,688

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for

Extensive Stage Lung Small Cell Carcinoma,

Location: Peabody MA, Boston MA, Burlington MA, Waterford CT,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase 2, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for

Metastatic Castration Sensitive Prostate Cancer (mCSPC),

Location: Commack NY, Seaford NY, Uniondale NY, Lake Success NY,

Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase 3, Recruiting

Optimal Ventilation for Cardiac Arrest

for

Cardiac Arrest (CA)

Location: Boston MA, New Hyde Park NY, Philadelphia PA,

Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for

Metastatic Clear Cell Renal Cell Carcinoma,

Location: Boston MA, New Haven CT, Sherbrooke, New York NY,

Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for

Growth Hormone Deficiency (GHD)

Location: Staten Island NY, Washington D.C. DC,

Sponsor: Lumos Pharma

Sex: All

Age: 3 - 11

Code: NCT06948214

Phase 3, Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for

Myeloproliferative Neoplasms

Location: New York NY, Baltimore MD, Chapel Hill NC,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase 1, Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for

Acute Myeloid Leukemia (AML)

Location: Worcester MA, Hartford CT, New Haven CT, New York NY,

Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase 3, Recruiting

SanaMente: A Peer-Led Program to Reduce Health Disparities in Rural Latino/a Communities

for

Depression and/or Anxiety in the Mild-to-moderate Range,

Location: Carbondale CO

Sponsor: University of Colorado, Boulder

Sex: All

Age: 18+

Code: NCT07705776

Recruiting

Phase 1b/2 Study of IV Sarilumab in Adult With RA

for

Rheumatoid Arthritis

Location: Duncansville PA, Hollywood FL, Hialeah FL,

Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07704580

Phase 1, Phase 2, Recruiting

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

for

Recessive Dystrophic Epidermolysis Bullosa

Location: Chicago IL, Galveston TX, Aurora CO, Palo Alto CA

Sponsor: Abeona Therapeutics, Inc

Sex: All

Age: 0+

Code: NCT07700966

Recruiting

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

for

Hypoparathyroidism

Location: The Bronx NY, Albany NY, Syracuse NY, Homestead FL,

Sponsor: MBX Biosciences

Sex: All

Age: 18+

Code: NCT07699471

Phase 3, Recruiting

Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation

for

Rotator Cuff Tears, Rotator Cuff Injuries, Surgery

Location: Bethesda MD, Durham NC, Chapel Hill NC, San Antonio TX,

Sponsor: Brooke Army Medical Center

Sex: All

Age: 18 - 65

Code: NCT06289686

Recruiting

Supporting VETerans With Kidney Disease Through Food As Medicine

for

Kidney Diseases, Food/Nutrition Insecurity, Diabetes,

Location: Aurora CO

Sponsor: VA Eastern Colorado Health Care System

Sex: All

Age: 18+

Code: NCT07194733

Recruiting

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

for

Severe Alopecia Areata

Location: Hershey PA, Washington D.C. DC, Miami FL, Charleston SC,

Sponsor: Pfizer

Sex: All

Age: 6 - 14

Code: NCT07029828

Phase 3, Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for

HER2 Expressing Solid Tumors

Location: New York NY, Hackensack NJ, Philadelphia PA,

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase 1, Phase 2, Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for

Malignant Neoplasm

Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase 1, Phase 2, Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for

Heart Transplant, Pediatric Heart Transplant, Rejection,

Location: Boston MA, New York NY, Hollywood FL, Gainesville FL,

Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for

Non-Small-Cell Lung Cancer,

Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,

Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

for

Breast Cancer

Location: Voorhees Township NJ, Jacksonville FL, Houston TX,

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07076485

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

for

Myasthenia Gravis

Location: New Bern NC, Clearwater FL, Greenville SC,

Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07673744

Phase 2, Recruiting

Popular cities in Colorado

Aurora Fort Collins Colorado Springs Boulder Greeley Denver Loveland

Paid Clinical Trials Colorado

Filter results

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Optimal Ventilation for Cardiac Arrest

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Interested in new trials?

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

SanaMente: A Peer-Led Program to Reduce Health Disparities in Rural Latino/a Communities

Phase 1b/2 Study of IV Sarilumab in Adult With RA

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation

Supporting VETerans With Kidney Disease Through Food As Medicine

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Non-invasive Prediction of EArly Cardiac rEjection

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

Popular cities in Colorado